That makes sense. It explains why Leo decided to g
Post# of 72435
![](/assets/46931549/no_avatar_available_thumb.jpg)
On top of that, if J&J (or whoever) is getting positive results from testing B as a medical device coating... Do you think perhaps a J&J type BP might decide that they need to go ahead and secure the Brilacidin franchise and it's $10 Billion+ in annual revenue potential?
Yeah. I can understand why Leo decided to go ahead with the B-UP POC trial...
![](/images/icons/icon_smile.gif)
Quote:
Besides B-OM, I think Leo plans to wait for the B-UP data before partnering. The B-UP trial should be really quick because it’s open-label and the treatment is six weeks, as opposed to twelve weeks for P. - sox040713
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)